BioHarvest Sciences Inc (fra:8MV0) Share Price

Company Profile

Business description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Contact
1140-625 Howe Street
VancouverBCV6C 2T6
CAN
T: +1 604 689-5722
https://www.bioharvest.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2025
Employees
87

Recommended

Shares have dropped 20% in the previous year due to concerns about tariffs.

Esther Holloway | 27 October 2025

Higher gold prices are making a difference to the bottom line but investors overly optimistic.

Jon Mills, CFA | 27 October 2025

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,295.80	26.20	-0.28%
CAC 40	8,226.93	12.25	-0.15%
DAX 40	24,314.64	5.86	0.02%
Dow JONES (US)	47,771.34	226.75	0.48%
FTSE 100	9,717.15	63.33	0.66%
HKSE	26,346.14	87.56	-0.33%
NASDAQ	23,701.17	63.72	0.27%
Nikkei 225	50,219.18	293.14	-0.58%
NZX 50 Index	13,402.66	11.07	0.08%
S&P 500	6,879.81	4.65	0.07%
S&P/ASX 200	9,012.50	16.30	-0.18%
SSE Composite Index	3,988.22	8.72	-0.22%